Table 2.
Adverse events | SNM | BonT-A | OMT |
---|---|---|---|
Re-operation | 8% | ||
Device Infection | 3% | ||
Urinary tract infection | 23% | 12% | |
Xerostomia | 16% | ||
Blur | 3% | ||
Constipation | 7% | ||
Change device - lead | 3% | ||
Change device - IPG | 3% | ||
Risk of femoral neck fracture | 8% |
SNM: sacral-neuromodulation; BonT-A: botulinum-toxin-A; OMT: optimized medical-therapy; IPG: implanted pulse generator.